Database Query Results : , , GSTP1/GSTπ

GSTP1/GSTπ, Glutathione S-transferase pi 1: Click to Expand ⟱
Source:
Type:
An enzyme that plays a crucial role in the detoxification of various substances, including carcinogens. It is also involved in the regulation of cellular processes, such as cell growth, differentiation, and apoptosis.
GSTP1 is overexpressed in various types of cancer, including prostate, breast, lung, and colon cancer. The overexpression of GSTP1 has been associated with cancer progression, metastasis, and poor prognosis.


Scientific Papers found: Click to Expand⟱
265- ALA,    Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies
- in-vitro, Pca, LNCaP - in-vitro, Pca, DU145
ROS↓, SOD↓, GSTP1/GSTπ↓, NRF2↓, p62↓, p62↑, SOD↑, p‑mTOR↑, Beclin-1↓, ROS↑, SOD1↑,
576- ART/DHA,    Profiling of Multiple Targets of Artemisinin Activated by Hemin in Cancer Cell Proteome
- Analysis, NA, NA
GSTP1/GSTπ↓, TfR1/CD71↓,
441- CUR,    Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p
- in-vitro, CRC, HCT116
ERCC1↓, Bcl-2↓, GSTP1/GSTπ↓, MRP↓, P-gp↓, miR-409-3p↑, survivin↓,
5014- PEITC,  Xan,    Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-κB and activates Nrf2 in pancreatic cancer cells
- in-vitro, PC, NA
NF-kB↓, NRF2↑, GSTP1/GSTπ↑, NQO1↑, SOD↑, TumCP↓,
992- PL,    Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer stem cells through modulation of GAPDH & FBP1
- in-vivo, BC, NA
EPR↓, Glycolysis↓, GAPDH↓, GSTP1/GSTπ↝, FBPase↑,
1941- PL,    Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
- in-vitro, HNSCC, NA
selectivity↑, eff↑, ROS↑, toxicity↑, GSH↓, GSSG↑, *GSSG∅, cl‑PARP↑, PUMA↑, GSTP1/GSTπ↓, ChemoSen↑,
2951- PL,  Aur,    Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells
- in-vitro, GBM, U87MG
GSH↓, eff↑, GSTP1/GSTπ↓,
4730- Se,    Association between plasma selenium level and NRF2 target genes expression in humans
- Human, Nor, NA
*NRF2↑, *GSTP1/GSTπ↓, *SOD2↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↓, 2,   GSSG↑, 1,   GSTP1/GSTπ↓, 5,   GSTP1/GSTπ↑, 1,   GSTP1/GSTπ↝, 1,   NQO1↑, 1,   NRF2↓, 1,   NRF2↑, 1,   ROS↓, 1,   ROS↑, 2,   SOD↓, 1,   SOD↑, 2,   SOD1↑, 1,  

Metal & Cofactor Biology

TfR1/CD71↓, 1,  

Core Metabolism/Glycolysis

ERCC1↓, 1,   FBPase↑, 1,   GAPDH↓, 1,   Glycolysis↓, 1,  

Cell Death

Bcl-2↓, 1,   PUMA↑, 1,   survivin↓, 1,  

Transcription & Epigenetics

miR-409-3p↑, 1,  

Autophagy & Lysosomes

Beclin-1↓, 1,   p62↓, 1,   p62↑, 1,  

DNA Damage & Repair

cl‑PARP↑, 1,  

Proliferation, Differentiation & Cell State

p‑mTOR↑, 1,  

Migration

TumCP↓, 1,  

Angiogenesis & Vasculature

EPR↓, 1,  

Barriers & Transport

MRP↓, 1,   P-gp↓, 1,  

Immune & Inflammatory Signaling

NF-kB↓, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 1,   eff↑, 2,   selectivity↑, 1,  

Functional Outcomes

toxicity↑, 1,  
Total Targets: 36

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

GSSG∅, 1,   GSTP1/GSTπ↓, 1,   NRF2↑, 1,   SOD2↓, 1,  
Total Targets: 4

Scientific Paper Hit Count for: GSTP1/GSTπ, Glutathione S-transferase pi 1
3 Piperlongumine
1 Alpha-Lipoic-Acid
1 Artemisinin
1 Curcumin
1 Phenethyl isothiocyanate
1 xanthohumol
1 Auranofin
1 Selenium
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:601  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page